July 13, 2017
Nippon Chemiphar and Nagase Medicals said on July 12 that the Intellectual Property High Court dismissed an appeal by Swiss-based Debiopharm International SA to block the distribution of their generic versions of the anticancer agent Elplat (oxaliplatin). In May last...read more